Anthony Hayes, CEO, Director at AIkido Pharma, holds 1.13M shares in Hoth Therapeutics (Ticker: HOTH), holds 52.18K shares in AIkido Pharma (Ticker: AIKI). Most recently, Anthony Hayes Sold ― shares of Hoth Therapeutics on May 29, 2020 for an estimated value of 500.00K.